Paper
Methylsulfonylmethane (MSM), an organosulfur compound, is effective against obesity-induced metabolic disorders in mice.
Published Oct 1, 2016 · Inês Sousa-Lima, Inês Sousa-Lima, Shin Young Park
Metabolism: clinical and experimental
Q1 SJR score
24
Citations
1
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Non-RCT
Animal StudyStudy Snapshot
MSM supplementation improves glucose and lipid metabolism in obesity-induced mice, potentially benefiting type 2 diabetes and fatty liver diseases.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Methylsulfonylmethane and boswellic acids versus glucosamine sulfate in the treatment of knee arthritis: Randomized trial
MSM and BA combination shows promising results in treating knee arthritis, with potential anti-inflammatory and chondroprotective effects, compared to glucosamine sulfate.
2016·40citations·A. Notarnicola et al.·International Journal of Immunopathology and Pharmacology
International Journal of Immunopathology and Pharmacology
Epigenetic Alterations in Human Liver From Subjects With Type 2 Diabetes in Parallel With Reduced Folate Levels.
Epigenetic changes in the liver from type 2 diabetes patients are linked to reduced circulating folate levels, potentially contributing to the development of the metabolic disease.
2015·164citations·E. Nilsson et al.·The Journal of clinical endocrinology and metabolism
The Journal of clinical endocrinology and metabolism
Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.
Glucose-lowering drugs in type 2 diabetes may improve cardiovascular risk factors, but long-term clinical trials are needed to confirm their effectiveness in preventing cardiovascular disease.
2015·249citations·E. Ferrannini et al.·European heart journal
European heart journal
Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease
Diet-induced NAFLD is linked to dysregulated hepatic methionine metabolism, leading to increased homocysteine levels and fibrosis in the liver.
2015·114citations·Tommy Pacana et al.·PLoS ONE
PLoS ONE
Betaine alleviates hepatic lipid accumulation via enhancing hepatic lipid export and fatty acid oxidation in rats fed with a high-fat diet - CORRIGENDUM
Betaine supplementation alleviates hepatic lipid accumulation in rats fed a high-fat diet by enhancing lipid export and fatty acid oxidation.
2015·35citations·Li Xu et al.·British Journal of Nutrition
British Journal of Nutrition
Citations
Methylsulfonylmethane ameliorates metabolic-associated fatty liver disease by restoring autophagy flux via AMPK/mTOR/ULK1 signaling pathway
MSM improves hepatic steatosis and obesity by enhancing autophagy flux through an AMPK/mTOR/ULK1-dependent signaling pathway.
2023·1citation·Daewon Han et al.·Frontiers in Pharmacology
Frontiers in Pharmacology
Sustained Delivery of Methylsulfonylmethane from Biodegradable Scaffolds Enhances Efficient Bone Regeneration
Incorporating MSM in biodegradable scaffolds significantly enhances bone regeneration and osteogenesis activity.
2022·3citations·Yueming Guo et al.·International Journal of Nanomedicine
International Journal of Nanomedicine
N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19
N-acetylcysteine (NAC) and other sulfur-donors can potentially prevent or reduce symptoms of COVID-19 by preserving the glycocalyx, which plays a crucial role in preventing and treating the disease.
2022·19citations·Heidi N du Preez et al.·Advances in Pharmacological and Pharmaceutical Sciences
Advances in Pharmacological and Pharmaceutical Sciences
Methylsulfonylmethane and Sesame Seed Oil Improve Dyslipidemia and Modulate Polyunsaturated Fatty Acid Metabolism in Two Mouse Models of Diabetes.
MSM and sesame seed oil treatment improves lipid profile and modulates polyunsaturated fatty acid metabolism in diabetic mice, potentially leading to improved clinical outcomes in diabetics.
2022·1citation·Cameron V. Fili et al.·Journal of medicinal food
Journal of medicinal food
Methylsulfonylmethane ameliorates inflammation via NF-κB and ERK/JNK-MAPK signaling pathway in chicken trachea and HD11 cells during Mycoplasma gallisepticum infection
MSM has protective effects on Mycoplasma gallisepticum-induced inflammation in chickens, providing a better strategy for protective intervention against this disease.
2022·11citations·Y. Miao et al.·Poultry Science
Poultry Science